Planet 13 Holdings (PLNH) Enterprise Value (2020 - 2026)
Planet 13 Holdings (PLNH) posted quarterly Enterprise Value of -$16.3 million for Q1 2026, up 7.67% year-over-year from -$15.1 million in Q1 2025, and down 4.38% quarter-over-quarter from -$15.6 million in Q4 2025.
Planet 13 Holdings (PLNH) Enterprise Value (2020 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has reported Enterprise Value for 7 consecutive years, with -$16.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Enterprise Value rose 7.67% year-over-year to -$16.3 million; the TTM figure through Mar 2026 stood at -$16.3 million (up 7.67% YoY), while the FY2025 annual figure was -$15.6 million, up 38.77% from the prior year.
- Enterprise Value fell to -$16.3 million in Q1 2026 per PLNH's latest filing, from -$15.6 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$15.6 million in Q4 2025 and bottomed at -$62.1 million in Q1 2022.
- Historically, Enterprise Value has averaged -$28.4 million across 5 years, with a median of -$24.5 million in 2023.
- On a YoY basis, Enterprise Value climbed as much as 61.39% in 2022 and fell as far as 37349.39% in 2022.
- Planet 13 Holdings' Enterprise Value stood at -$38.8 million in 2022, then surged by 55.45% to -$17.3 million in 2023, then plunged by 47.18% to -$25.4 million in 2024, then jumped by 38.77% to -$15.6 million in 2025, then fell by 4.38% to -$16.3 million in 2026.
- Business Quant data shows PLNH's Enterprise Value at -$16.3 million in Q1 2026, -$15.6 million in Q4 2025, and -$17.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | -164.00 Mn |
| 10 | Planet 13 Holdings | 50.16 Mn | 33.68 Mn | 12.32 Mn | -16.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -16.48 Mn |
| Mar 31, 2026 | -16.26 Mn |
| Dec 31, 2025 | -15.58 Mn |
| Sep 30, 2025 | -17.18 Mn |
| Jun 30, 2025 | -15.85 Mn |
| Mar 31, 2025 | -17.61 Mn |
| Dec 31, 2024 | -25.44 Mn |
| Sep 30, 2024 | -29.46 Mn |
| Jun 30, 2024 | -28.72 Mn |
| Mar 31, 2024 | -22.82 Mn |
| Dec 31, 2023 | -17.28 Mn |
| Sep 30, 2023 | -20.49 Mn |
| Jun 30, 2023 | -24.46 Mn |
| Mar 31, 2023 | -26.92 Mn |
| Dec 31, 2022 | -38.79 Mn |
| Sep 30, 2022 | -50.88 Mn |
| Jun 30, 2022 | -52.62 Mn |
| Mar 31, 2022 | -62.14 Mn |
| Dec 31, 2021 | -58.59 Mn |
| Sep 30, 2021 | -1.62 Mn |